| Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
| Luciferase | 7 | 0 | 0 | 7 |
| glp-1 receptor, partial | 5 | 0 | 0 | 5 |
| hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
| RAR-related orphan receptor gamma | 9 | 0 | 0 | 9 |
| ATAD5 protein, partial | 5 | 0 | 0 | 5 |
| Fumarate hydratase | 4 | 0 | 0 | 4 |
| TDP1 protein | 12 | 0 | 0 | 12 |
| GLI family zinc finger 3 | 12 | 0 | 0 | 12 |
| AR protein | 15 | 0 | 0 | 15 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
| progesterone receptor | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
| retinoic acid nuclear receptor alpha variant 1 | 13 | 0 | 0 | 13 |
| retinoid X nuclear receptor alpha | 7 | 0 | 0 | 7 |
| estrogen-related nuclear receptor alpha | 14 | 0 | 0 | 14 |
| farnesoid X nuclear receptor | 9 | 0 | 0 | 9 |
| pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
| estrogen nuclear receptor alpha | 17 | 0 | 0 | 17 |
| polyprotein | 4 | 0 | 0 | 4 |
| 67.9K protein | 4 | 0 | 0 | 4 |
| peroxisome proliferator activated receptor gamma | 10 | 0 | 0 | 10 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
| caspase-3 | 1 | 0 | 0 | 1 |
| IDH1 | 5 | 0 | 0 | 5 |
| euchromatic histone-lysine N-methyltransferase 2 | 16 | 0 | 0 | 16 |
| aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 9 | 0 | 0 | 9 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 8 | 0 | 0 | 8 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| Histone H2A.x | 7 | 0 | 0 | 7 |
| cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
| chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 11 | 0 | 0 | 11 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 5 | 0 | 0 | 5 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| geminin | 13 | 0 | 0 | 13 |
| Vif | 0 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 7 | 0 | 0 | 7 |
| survival motor neuron protein isoform d | 7 | 0 | 0 | 7 |
| muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
| Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 9 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Bile salt export pump | 0 | 14 | 0 | 14 |
| Interferon beta | 6 | 0 | 0 | 6 |
| Cellular tumor antigen p53 | 13 | 0 | 0 | 13 |
| Integrin beta-3 | 4 | 0 | 0 | 4 |
| Integrin alpha-IIb | 4 | 0 | 0 | 4 |
| Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 6 | 0 | 0 | 6 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
| ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
| Ataxin-2 | 7 | 0 | 0 | 7 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
| Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 3 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| GLS protein | 5 | 0 | 0 | 5 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 4 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 3 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 3 |
| 60 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 4 | 0 | 0 | 4 |
| 10 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
| Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 4 | 0 | 4 |
| Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 4 |
| Efflux transporter | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| 60 kDa chaperonin | 0 | 4 | 0 | 4 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 3 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 1 | 4 |
| 10 kDa chaperonin | 0 | 4 | 0 | 4 |
| Metallo-b-lactamase | 0 | 0 | 0 | 4 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 3 |
| Histamine H3 receptor | 0 | 0 | 0 | 3 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 5 |
| Beta-lactamase VIM-1 | 0 | 1 | 0 | 4 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| acetylcholinesterase | 6 | 0 | 0 | 6 |
| thioredoxin reductase | 8 | 0 | 0 | 8 |
| phosphopantetheinyl transferase | 5 | 0 | 0 | 5 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| Microtubule-associated protein tau | 8 | 0 | 0 | 8 |
| thioredoxin glutathione reductase | 6 | 0 | 0 | 6 |
| EWS/FLI fusion protein | 8 | 0 | 0 | 8 |
| G | 4 | 0 | 0 | 4 |
| P53 | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| arylsulfatase A | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
| hemoglobin subunit beta | 4 | 0 | 0 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 12 | 0 | 0 | 12 |
| cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 4 | 0 | 1 | 5 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 0 | 1 | 5 |
| Nuclear receptor ROR-gamma | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 0 | 1 | 5 |
| GABA theta subunit | 4 | 0 | 1 | 5 |
| Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | 4 | 0 | 1 | 5 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| DNA topoisomerase | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
| histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Telomerase reverse transcriptase | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme ScaI | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-2-alpha | 0 | 1 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 2 | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-1 | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme PstI | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme EcoRI | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 2 | 4 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 2 | 1 | 7 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme BamHI | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 1 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Type-2 restriction enzyme HindIII | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 0 | 0 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Arginase | 0 | 2 | 0 | 2 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 1 | 1 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 0 | 0 | 2 |
| Delta-type opioid receptor | 0 | 0 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 2 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Melatonin receptor type 1A | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1B | 0 | 0 | 1 | 1 |
| Death-associated protein kinase 1 | 0 | 2 | 0 | 2 |
| Beta-secretase 1 | 0 | 4 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| USP1 protein, partial | 6 | 0 | 0 | 6 |
| vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Vitamin D3 receptor | 0 | 1 | 1 | 5 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 3 |
| Beta-lactamase TEM | 0 | 1 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 5 | 0 | 0 | 5 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Amyloid-beta precursor protein | 1 | 2 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
| Trypsin | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| Coagulation factor VII | 0 | 2 | 0 | 2 |
| Aromatase | 0 | 3 | 0 | 3 |
| Tissue factor | 0 | 2 | 0 | 2 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 3 | 3 |
| Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Synaptojanin-2 | 0 | 1 | 0 | 1 |
| Synaptojanin-1 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 4 |
| Hepatocyte growth factor receptor | 0 | 3 | 0 | 3 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 2 | 0 | 2 |
| Apoptosis regulator Bcl-2 | 0 | 3 | 0 | 3 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
| Fatty acid synthase | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-5 | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 2 | 0 | 2 | 0 | 2 |
| Alpha-synuclein | 0 | 2 | 0 | 2 |
| DNA repair protein RAD52 homolog | 0 | 2 | 0 | 2 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 2 | 0 | 2 |
| ELAV-like protein 3 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
| Reverse transcriptase/RNaseH | 0 | 2 | 0 | 2 |
| Enoyl-acyl-carrier protein reductase | 0 | 4 | 0 | 4 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 4 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
| Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 0 | 1 | 1 |
| Chain A, POLYMERASE PA | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| galactokinase | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| Polycomb protein EED | 0 | 0 | 1 | 1 |
| NAD kinase | 0 | 2 | 1 | 3 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 0 | 1 | 2 |
| Polymerase acidic protein | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 1 | 0 | 1 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Matrilysin | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Alpha-amylase 1A | 0 | 1 | 0 | 1 |
| Microtubule-associated protein tau | 0 | 1 | 0 | 1 |
| CPG DNA methylase | 0 | 1 | 0 | 1 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Phosphoglycerate mutase 1 | 0 | 1 | 0 | 1 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 0 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Signal transducer and activator of transcription 1-alpha/beta | 0 | 0 | 1 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
| Squalene monooxygenase | 0 | 1 | 0 | 1 |
| BH3-interacting domain death agonist | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 0 | 1 | 0 | 1 |
| Lactoperoxidase | 0 | 0 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 1 | 0 | 1 |
| Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
| Bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] reductase | 0 | 1 | 0 | 1 |
| MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
| CREB-binding protein | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT2B | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 2 | 0 | 1 | 0 | 1 |
| Bcl2-associated agonist of cell death | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT5 | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 1 | 2 |
| Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 0 | 0 | 1 |
| Mast/stem cell growth factor receptor Kit | 0 | 1 | 1 | 2 |
| Breakpoint cluster region protein | 0 | 0 | 1 | 1 |
| Platelet-derived growth factor receptor alpha | 0 | 1 | 1 | 2 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase IMP-1 | 0 | 0 | 0 | 2 |
| BlaVIM-1 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Caspase-4 | 0 | 1 | 0 | 1 |
| Caspase-5 | 0 | 1 | 0 | 1 |
| Caspase-9 | 0 | 1 | 0 | 1 |
| Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
| Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
| UDP-glucose 6-dehydrogenase | 0 | 1 | 0 | 1 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 0 | 1 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 1 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| Chain A, Adipocyte Lipid-binding Protein | 0 | 0 | 1 | 1 |
| Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
| Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
| Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| putative potassium channel subunit | 0 | 0 | 1 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 0 | 1 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, adipocyte | 0 | 2 | 0 | 2 |
| Protein kinase C alpha type | 0 | 0 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor delta | 0 | 0 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 1 | 0 | 1 | 2 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 2 | 2 | 4 |
| Thyroid hormone receptor beta | 0 | 2 | 2 | 4 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
| Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 12 | 0 | 0 | 0 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 0 | 0 | 1 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 0 | 0 | 1 |
| Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Tryprostatin B synthase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |